NO996206D0 - Farnesyltransferase inhibitorer i kombinasjon med HMG COA reduktase inhibitorer for behandling av cancer - Google Patents

Farnesyltransferase inhibitorer i kombinasjon med HMG COA reduktase inhibitorer for behandling av cancer

Info

Publication number: NO996206D0
Authority: NO; Norway
Prior art keywords: inhibitors; cancer; treatment; combination; coa reductase
Prior art date: 1997-06-16

Application number

NO996206A

Other languages

English (en)

Other versions

NO996206L (no

Inventor

Shama Mohammed Kajiji

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-16

Filing date

1999-12-15

Publication date

1999-12-15

1999-12-15 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-12-15 Publication of NO996206D0 publication Critical patent/NO996206D0/no

2000-02-15 Publication of NO996206L publication Critical patent/NO996206L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO996206A 1997-06-16 1999-12-15 Farnesyltransferase inhibitorer i kombinasjon med HMG COA reduktase inhibitorer for behandling av cancer NO996206L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4963897P	1997-06-16	1997-06-16
PCT/IB1998/000881 WO1998057633A1 (en)	1997-06-16	1998-06-05	FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER

Publications (2)

Publication Number	Publication Date
NO996206D0 true NO996206D0 (no)	1999-12-15
NO996206L NO996206L (no)	2000-02-15

Family

ID=21960890

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO996206A NO996206L (no)	1997-06-16	1999-12-15	Farnesyltransferase inhibitorer i kombinasjon med HMG COA reduktase inhibitorer for behandling av cancer

Country Status (37)

Country	Link
EP (1)	EP0986387B1 (no)
JP (1)	JP3713051B2 (no)
KR (1)	KR100392573B1 (no)
CN (1)	CN1259868A (no)
AP (1)	AP9801261A0 (no)
AR (1)	AR013090A1 (no)
AT (1)	ATE235905T1 (no)
BG (1)	BG103946A (no)
BR (1)	BR9810616A (no)
CA (1)	CA2294399C (no)
CO (1)	CO4950607A1 (no)
DE (1)	DE69812933T2 (no)
DK (1)	DK0986387T3 (no)
DZ (1)	DZ2518A1 (no)
EA (1)	EA199901043A1 (no)
ES (1)	ES2196559T3 (no)
GT (1)	GT199800081A (no)
HN (1)	HN1998000091A (no)
HR (1)	HRP980328B1 (no)
HU (1)	HUP0004624A3 (no)
ID (1)	ID23014A (no)
IL (1)	IL132765A0 (no)
IS (1)	IS5259A (no)
MA (1)	MA24569A1 (no)
NO (1)	NO996206L (no)
NZ (1)	NZ500662A (no)
OA (1)	OA11231A (no)
PA (1)	PA8453601A1 (no)
PE (1)	PE82899A1 (no)
PL (1)	PL337651A1 (no)
PT (1)	PT986387E (no)
SK (1)	SK169699A3 (no)
TN (1)	TNSN98088A1 (no)
TR (1)	TR199903074T2 (no)
UA (1)	UA57081C2 (no)
WO (1)	WO1998057633A1 (no)
ZA (1)	ZA985182B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU68900A (sh) *	1998-05-12	2002-12-10	Warner-Lambert Company	Kombinacije inhibitora protein farnesiltransferaze i hmg coa reduktaze i njihova upotreba u tretmanu raka
WO2000016778A1 (en) *	1998-09-24	2000-03-30	Merck & Co., Inc.	A method of treating cancer
EP1006113A1 (en) *	1998-12-02	2000-06-07	Pfizer Products Inc.	Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
WO2000067737A2 (en) *	1999-05-07	2000-11-16	The Brigham And Women's Hospital, Inc.	USE OF HMGCoA REDUCTASE INHIBITORS IN THE PREVENTION OF DISEASES WHOSE PATHOGENESIS IS DEPENDENT ON NEOVASCULARIZATION
US6710058B2 (en)	2000-11-06	2004-03-23	Bristol-Myers Squibb Pharma Company	Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
JP2004516287A (ja)	2000-12-19	2004-06-03	ファイザー・プロダクツ・インク	６−［（４−クロロ−フェニル）−ヒドロキシ−（３−メチル−３ｈ−イミダゾール−４−イル）−メチル］−４−（３−エチニル−フェニル）−１−メチル−１ｈ−キノリン−２−オン，２，３−ジヒドロキシブタン二酸塩の結晶形および製造方法
EP1406609B1 (en)	2000-12-21	2006-09-06	Nitromed, Inc.	Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
US20020151563A1 (en) *	2001-03-29	2002-10-17	Pfizer Inc.	Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the inhibition of abnormal cell growth
US6740757B2 (en)	2001-08-29	2004-05-25	Pfizer Inc	Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer
EP1555021A1 (en) *	2004-01-16	2005-07-20	National Health Research Institutes	Combinations of a mevalonate pathway inhibitor and a PPAR-gamma agonist for treating cancer
US8168667B2 (en)	2006-05-31	2012-05-01	Galapagos Nv	Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
GB2463514C (en)	2008-09-11	2018-09-26	Galapagos Nv	Imidazolidine compounds and uses therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE302613T1 (de) *	1995-08-09	2005-09-15	Banyu Pharma Co Ltd	Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids

1998
- 1998-05-06 UA UA99126842A patent/UA57081C2/uk unknown
- 1998-06-05 KR KR10-1999-7011860A patent/KR100392573B1/ko not_active Expired - Fee Related
- 1998-06-05 CA CA002294399A patent/CA2294399C/en not_active Expired - Fee Related
- 1998-06-05 NZ NZ500662A patent/NZ500662A/en unknown
- 1998-06-05 PT PT98921688T patent/PT986387E/pt unknown
- 1998-06-05 IL IL13276598A patent/IL132765A0/xx unknown
- 1998-06-05 EA EA199901043A patent/EA199901043A1/ru unknown
- 1998-06-05 DE DE69812933T patent/DE69812933T2/de not_active Expired - Fee Related
- 1998-06-05 CN CN98805968A patent/CN1259868A/zh active Pending
- 1998-06-05 ES ES98921688T patent/ES2196559T3/es not_active Expired - Lifetime
- 1998-06-05 JP JP50403099A patent/JP3713051B2/ja not_active Expired - Fee Related
- 1998-06-05 EP EP98921688A patent/EP0986387B1/en not_active Expired - Lifetime
- 1998-06-05 ID IDW991597A patent/ID23014A/id unknown
- 1998-06-05 WO PCT/IB1998/000881 patent/WO1998057633A1/en not_active Ceased
- 1998-06-05 HU HU0004624A patent/HUP0004624A3/hu unknown
- 1998-06-05 PL PL98337651A patent/PL337651A1/xx unknown
- 1998-06-05 DK DK98921688T patent/DK0986387T3/da active
- 1998-06-05 SK SK1696-99A patent/SK169699A3/sk unknown
- 1998-06-05 BR BR9810616-3A patent/BR9810616A/pt not_active Application Discontinuation
- 1998-06-05 TR TR1999/03074T patent/TR199903074T2/xx unknown
- 1998-06-05 AT AT98921688T patent/ATE235905T1/de not_active IP Right Cessation
- 1998-06-09 HN HN1998000091A patent/HN1998000091A/es unknown
- 1998-06-11 AP APAP/P/1998/001261A patent/AP9801261A0/en unknown
- 1998-06-12 PE PE1998000500A patent/PE82899A1/es not_active Application Discontinuation
- 1998-06-12 AR ARP980102812A patent/AR013090A1/es unknown
- 1998-06-15 PA PA19988453601A patent/PA8453601A1/es unknown
- 1998-06-15 DZ DZ980128A patent/DZ2518A1/xx active
- 1998-06-15 TN TNTNSN98088A patent/TNSN98088A1/fr unknown
- 1998-06-15 GT GT199800081A patent/GT199800081A/es unknown
- 1998-06-15 MA MA25114A patent/MA24569A1/fr unknown
- 1998-06-15 ZA ZA9805182A patent/ZA985182B/xx unknown
- 1998-06-16 HR HR980328A patent/HRP980328B1/xx not_active IP Right Cessation
- 1998-06-16 CO CO98034148A patent/CO4950607A1/es unknown
1999
- 1999-11-19 IS IS5259A patent/IS5259A/is unknown
- 1999-12-03 BG BG103946A patent/BG103946A/bg unknown
- 1999-12-10 OA OA9900276A patent/OA11231A/en unknown
- 1999-12-15 NO NO996206A patent/NO996206L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AP9801261A0 (en)	1999-12-11
IL132765A0 (en)	2001-03-19
HN1998000091A (es)	1999-09-29
CA2294399C (en)	2004-03-16
HUP0004624A2 (hu)	2001-10-28
DZ2518A1 (fr)	2003-02-01
CA2294399A1 (en)	1998-12-23
PA8453601A1 (es)	2000-05-24
BG103946A (bg)	2000-07-31
JP3713051B2 (ja)	2005-11-02
HRP980328A2 (en)	1999-04-30
DK0986387T3 (da)	2003-07-14
BR9810616A (pt)	2000-09-12
AR013090A1 (es)	2000-12-13
TR199903074T2 (xx)	2000-05-22
ID23014A (id)	1999-12-30
ES2196559T3 (es)	2003-12-16
CO4950607A1 (es)	2000-09-01
OA11231A (en)	2003-05-26
NZ500662A (en)	2001-10-26
PT986387E (pt)	2003-06-30
DE69812933D1 (de)	2003-05-08
DE69812933T2 (de)	2003-11-06
PE82899A1 (es)	1999-08-26
EP0986387A1 (en)	2000-03-22
CN1259868A (zh)	2000-07-12
GT199800081A (es)	1999-12-07
KR20010013839A (ko)	2001-02-26
SK169699A3 (en)	2000-06-12
ATE235905T1 (de)	2003-04-15
UA57081C2 (uk)	2003-06-16
MA24569A1 (fr)	1998-12-31
HRP980328B1 (en)	2002-06-30
WO1998057633A1 (en)	1998-12-23
IS5259A (is)	1999-11-19
EP0986387B1 (en)	2003-04-02
TNSN98088A1 (fr)	2005-03-15
ZA985182B (en)	1999-12-17
KR100392573B1 (ko)	2003-07-23
HUP0004624A3 (en)	2002-11-28
JP2000513031A (ja)	2000-10-03
AU724676B2 (en)	2000-09-28
AU7445998A (en)	1999-01-04
NO996206L (no)	2000-02-15
PL337651A1 (en)	2000-08-28
EA199901043A1 (ru)	2000-06-26

Publication	Publication Date	Title
NO985652D0 (no)	1998-12-03	Anvendelse av naaladaseinhibitorer ved behandling av kreft
TR199800436A3 (tr)	1998-10-21	Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
BR9508886A (pt)	1997-12-30	Compostos e métodos para o tratamento de câncer
DE69831222D1 (de)	2005-09-22	Verbindungen zur immundiagnose von prostatakrebs und deren verwendung
AU2003200731A1 (en)	2003-05-01	Compositions and methods for the treatment of tumor
AU2003200722A1 (en)	2003-05-01	Compositions and methods for the treatment of tumor
AU2003200740A1 (en)	2003-06-12	Compositions and methods for the treatment of tumor
NO20015516L (no)	2002-01-11	Preparater og anvendelser av ET743 for behandling av kreft
KR100510795B1 (en)	2005-08-30	Compositions and Methods for the Treatment of Tumor
DK0942754T3 (da)	2003-08-04	Konjugater anvendelige til behandlingen af prostatacancer
NO996206L (no)	2000-02-15	Farnesyltransferase inhibitorer i kombinasjon med HMG COA reduktase inhibitorer for behandling av cancer
NO20020358L (no)	2002-03-21	Anvendelse av etodolac til behandling av kreft
AU6062900A (en)	2001-01-22	Substituted indole compounds and their use for the treatment of cancer
IL139502A0 (en)	2001-11-25	Combination of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
AU5680900A (en)	2001-01-31	Combination of mtp inhibitors and hmg-coa reductase inhibitors and the use thereof in medicaments
DE50011084D1 (de)	2005-10-06	Verwendung von azolen zur prävention von strahlen-induziertem hautkrebs
AU2002327643A1 (en)	2003-04-01	Detection and treatment of cancers of the liver
SI0986387T1 (en)	2003-10-31	FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
HUP0201597A3 (en)	2003-04-28	Antilipemic combunations comprising hmg-coa reductase inhibitors and carnitines
PT1064014E (pt)	2005-06-30	Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus
EP1135141A4 (en)	2003-03-05	PHOSPHOLIPASE INHIBITORS FOR TREATING CANCER
PL337343A1 (en)	2000-08-14	Method of obtaining drugs comprising inhibitors of hmg coa reductase
HK1048585A (en)	2003-04-11	Substituted guanidines for the treatment of cancer and pain
KR100511819B1 (en)	2005-09-02	Compositions and Methods for the Treatment of Tumor
AU2002303182A1 (en)	2002-10-15	Farnesyl transferase inhibitors in combination with hmg coa reductase inhibitors for the inhibition for the treatment of cancer

Legal Events

Date	Code	Title	Description
2005-04-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application